ISR Reports: PPD Receives Top Marks for Customer Loyalty and Value in Phase I
Informing the drug development and commercialization industry
CARY, N.C.--(BUSINESS WIRE)--Jul 19, 2012 - Industry Standard Research (ISR) today announced the availability of a new report titled 2012 CRO Quality Benchmarking – Phase I Service Providers, which provides service quality profiles for 12 Phase I CROs.
“PPD received higher ratings than any other Phase I CRO we surveyed in two key areas: Customer Loyalty and Overall Value,” explained Kevin Olson, CEO of ISR. “They also regularly received ratings across the service dimensions indicating performance that exceeded their customers' expectations.”
ISR's report compiles data from 146 service encounters across 9 critical Phase I service dimensions, including attributes like Quality of the Phase I Unit's Lead Investigator, Ability to Quickly Recruit Volunteers or Patients, Meeting Schedules and Timelines, Breadth of Services, and Low Cost.
In addition to service quality ratings, ISR's report also provides an analysis of sponsors' Phase I outsourcing behaviors, attitudes, beliefs, and intentions; and has sponsors rank attributes that drive the selection of clinical pharmacology service providers. “More sponsors chose Access to Patient Populations among their top 5 than any of the other 21 attribute choices," Olson explained. "Every piece of research we conduct in the Phase I market indicates a growing use of patients in these early studies."
ISR's report provides sponsors and service providers with unique opportunities to evaluate Phase I services.
“This report allows sponsors to leverage the service encounters of 61 other professionals, not just their own, to evaluate their choices against their individual organizational, or project needs.” Olson continued. “For Phase I Units, the report provides unbiased customer insight and feedback on the quality of their services (and their competitors' services), allowing for a more thorough evaluation of products and services.”
The report includes full profiles for the following Phase I CROs: Bioclinica, Cetero, Charles River, Covance, DCRI-Duke, ICON, PAREXEL, PharmaNet/i3, PPD, PRA, Quintiles, and West Coast Clinical Trials.
About Industry Standard Research
Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries. With over a decade of experience, ISR delivers an unmatched level of domain expertise. For more information about ISR's off-the-shelf intelligence and custom research offerings, please visit the company's Web site at www.ISRreports.com, email firstname.lastname@example.org, or follow ISR on Twitter @ISRreports.
Contact: Industry Standard Research (ISR)
Kevin Olson, 919-301-0106
Posted: July 2012